Quarterlytics / Healthcare / Biotechnology / Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

VYGR · NASDAQ Healthcare

Claim this profile

Ticker VYGR

Exchange NASDAQ

Sector Healthcare

Industry Biotechnology

Employees 172

Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Company Profile

Voyager Therapeutics: Can Tau-Focused Conviction Outrun the Cash Clock?

Alfred Sandrock calls tau the most important target in Alzheimer's disease, and Voyager Therapeutics has two wholly owned programs aimed at it: an antibody and …

VYGR Jun 22, 2026